Nam-Joon Cho1, Choongho Lee2, Phillip S Pang3, Edward A Pham3, Benjamin Fram1, Khanh Nguyen1, Anming Xiong1, Ella H Sklan2, Menashe Elazar1, Elif S Koytak2, Caroline Kersten2, Kay K Kanazawa4, Curtis W Frank4, Jeffrey S Glenn5. 1. Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California. 2. Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California. 3. Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California. 4. Department of Chemical Engineering, Stanford University, Stanford, California. 5. Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California; Veterans Administration Medical Center, Palo Alto, California. Electronic address: jeffrey.glenn@stanford.edu.
Abstract
BACKGROUND & AIMS: Phosphoinositides (PIs) bind and regulate localization of proteins via a variety of structural motifs. PI 4,5-bisphosphate (PI[4,5]P2) interacts with and modulates the function of several proteins involved in intracellular vesicular membrane trafficking. We investigated interactions between PI(4,5)P2 and hepatitis C virus (HCV) nonstructural protein 5A (NS5A) and effects on the viral life cycle. METHODS: We used a combination of quartz crystal microbalance, circular dichroism, molecular genetics, and immunofluorescence to study specific binding of PI(4,5)P2 by the HCV NS5A protein. We evaluated the effects of PI(4,5)P2 on the function of NS5A by expressing wild-type or mutant forms of Bart79I or FL-J6/JFH-5'C19Rluc2AUbi21 RNA in Huh7 cells. We also studied the effects of strategies designed to inhibit PI(4,5)P2 on HCV replication in these cells. RESULTS: The N-terminal amphipathic helix of NS5A bound specifically to PI(4,5)P2, inducing a conformational change that stabilized the interaction between NS5A and TBC1D20, which is required for HCV replication. A pair of positively charged residues within the amphipathic helix (the basic amino acid PI(4,5)P2 pincer domain) was required for PI(4,5)P2 binding and replication of the HCV-RNA genome. A similar motif was found to be conserved across all HCV isolates, as well as amphipathic helices of many pathogens and apolipoproteins. CONCLUSIONS: PI(4,5)P2 binds to HCV NS5A to promote replication of the viral RNA genome in hepatocytes. Strategies to disrupt this interaction might be developed to inhibit replication of HCV and other viruses.
BACKGROUND & AIMS: Phosphoinositides (PIs) bind and regulate localization of proteins via a variety of structural motifs. PI 4,5-bisphosphate (PI[4,5]P2) interacts with and modulates the function of several proteins involved in intracellular vesicular membrane trafficking. We investigated interactions between PI(4,5)P2 and hepatitis C virus (HCV) nonstructural protein 5A (NS5A) and effects on the viral life cycle. METHODS: We used a combination of quartz crystal microbalance, circular dichroism, molecular genetics, and immunofluorescence to study specific binding of PI(4,5)P2 by the HCV NS5A protein. We evaluated the effects of PI(4,5)P2 on the function of NS5A by expressing wild-type or mutant forms of Bart79I or FL-J6/JFH-5'C19Rluc2AUbi21 RNA in Huh7 cells. We also studied the effects of strategies designed to inhibit PI(4,5)P2 on HCV replication in these cells. RESULTS: The N-terminal amphipathic helix of NS5A bound specifically to PI(4,5)P2, inducing a conformational change that stabilized the interaction between NS5A and TBC1D20, which is required for HCV replication. A pair of positively charged residues within the amphipathic helix (the basic amino acid PI(4,5)P2 pincer domain) was required for PI(4,5)P2 binding and replication of the HCV-RNA genome. A similar motif was found to be conserved across all HCV isolates, as well as amphipathic helices of many pathogens and apolipoproteins. CONCLUSIONS: PI(4,5)P2 binds to HCV NS5A to promote replication of the viral RNA genome in hepatocytes. Strategies to disrupt this interaction might be developed to inhibit replication of HCV and other viruses.
Authors: D Siagris; M Christofidou; G J Theocharis; N Pagoni; C Papadimitriou; A Lekkou; K Thomopoulos; I Starakis; A C Tsamandas; C Labropoulou-Karatza Journal: J Viral Hepat Date: 2006-01 Impact factor: 3.728
Authors: Donna M Tscherne; Christopher T Jones; Matthew J Evans; Brett D Lindenbach; Jane A McKeating; Charles M Rice Journal: J Virol Date: 2006-02 Impact factor: 5.103
Authors: Luyun Huang; Elena V Sineva; Michele R S Hargittai; Suresh D Sharma; Mehul Suthar; Kevin D Raney; Craig E Cameron Journal: Protein Expr Purif Date: 2004-09 Impact factor: 1.650
Authors: Germana Grassi; Giorgia Di Caprio; Gian Maria Fimia; Giuseppe Ippolito; Marco Tripodi; Tonino Alonzi Journal: World J Gastroenterol Date: 2016-02-14 Impact factor: 5.742
Authors: Florentine U Rutaganira; Melissa L Fowler; Jacob A McPhail; Michael A Gelman; Khanh Nguyen; Anming Xiong; Gillian L Dornan; Brandon Tavshanjian; Jeffrey S Glenn; Kevan M Shokat; John E Burke Journal: J Med Chem Date: 2016-02-26 Impact factor: 7.446
Authors: Esther L Ashworth Briggs; Rafael G B Gomes; Malaz Elhussein; William Collier; I Stuart Findlow; Syma Khalid; Chris J McCormick; Philip T F Williamson Journal: Biochim Biophys Acta Date: 2015-05-02
Authors: Cristina M Dorobantu; Lucian Albulescu; Christian Harak; Qian Feng; Mirjam van Kampen; Jeroen R P M Strating; Alexander E Gorbalenya; Volker Lohmann; Hilde M van der Schaar; Frank J M van Kuppeveld Journal: PLoS Pathog Date: 2015-09-25 Impact factor: 6.823
Authors: Djoshkun Shengjuler; Yan Mei Chan; Simou Sun; Ibrahim M Moustafa; Zhen-Lu Li; David W Gohara; Matthias Buck; Paul S Cremer; David D Boehr; Craig E Cameron Journal: Structure Date: 2017-12-05 Impact factor: 5.006